AlphaFold predicted structure
HMGCL · P35914

Mean pLDDT
92.0/ 100
Very high
325 residues
Confidence breakdown
- Very high(≥ 90)87%
- Confident(70–90)3%
- Low(50–70)3%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
3-hydroxy-3-methylglutaryl-CoA lyase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalAdult onset leukodystrophy
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
+3 more panels — install the extension to see the full list inline on any page.
3-hydroxy-3-methylglutaric aciduria
long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
hereditary disease
Intellectual disability
neurodegenerative disease
hepatocellular carcinoma
nasopharyngeal carcinoma
lung cancer
lung carcinoma
nonpapillary renal cell carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Hydroxymethylglutaryl-CoA lyase, mitochondrial
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase that catalyzes a cation-dependent cleavage of (S)-3-hydroxy-3-methylglutaryl-CoA into acetyl-CoA and acetoacetate, a key step in ketogenesis. Terminal step in leucine catabolism. Ketone bodies (beta-hydroxybutyrate, acetoacetate and acetone) are essential as an alternative source of energy to glucose, as lipid precursors and as regulators of metabolism
HMGCL · P35914

Mean pLDDT
92.0/ 100
Very high
325 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0